LANSOPRAZOLE EG 15 mg, orodispersible tablet 14 tablets
Active ingredients: Lansoprazole
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LANSOPRAZOLE EG 15 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 14 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64368132CIP72793252CIP133400927932526Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LANSOPRAZOLEcomprimé | 15 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.